摘要:
Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.
摘要:
Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.
摘要:
Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.
摘要:
This invention provides for a compound of formula (I), or a pharmaceutically acceptable salt thereof, wherein RA, RB, R2 and R4 are defined herein. The compounds of formula (I) and pharmaceutically acceptable salts thereof are cationic lipids useful in the delivery of biologically active agents to cells and tissues.
摘要:
Described herein are microneedle drug delivery systems comprising a pharmaceutical compositions comprising pharmaceutically active agents (e.g., cannabidiol and prodrugs of cannabidiol) and microneedle arrays suitable for local and systemic delivery of the active agent to a mammal. Also described herein are methods of using a microneedle transdermal or topical drug delivery systems comprising pharmaceutical compositions, comprising cannabidiol and prodrugs of cannabidiol, and microneedle arrays in the treatment disease, including pancreatitis and pancreatic cancer.
摘要:
The invention relates to amphiphilic compounds of the general formula I ##STR1## which have at least two hydrophilic and at least two hydrophobic groups and are based on carbonic acid derivatives.The spacer A is an aliphatic, cyclic or acyclic or an aromatic di-, oligo- or polycarbonate of the formula II: ##STR2## The amphiphilic compounds according to this invention are mostly surface-active and are suitable as emulsifiers, demulsifiers, detergents, dispersants and hydrotropes for industrial and domestic use, in particular in the fields of metalworking, ore extraction, surface finishing, plastics processing, washing and cleaning, cleaning of hard surfaces, manual dishwashing compositions, cosmetics, medicine and food processing and preparation.
摘要:
Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.
摘要:
Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.
摘要:
A process for the preparation of a compound or polymer having at least one functional group selected from hydroxyl, thiol, amino and carboxylic acid groups is characterized in that a compound or polymer (A) containing a group of formula (I), ##STR1## where Q represents O or S and X represents --O--, --S--, --NH-- or a direct bond, the group being linked to the remainder of the compound or polymer through a carbon atom, is reacted with a compound (B) containing at least two functional groups selected from hydroxyl, thiol, amino and carboxylic acid groups, one of which functional groups (II) reacts with the group of formula (I) and one of which functional groups (III) is substantially unreactive with the group of formula (I) under the conditions of reaction, so that the compound (B) becomes bonded to (A) through the reaction of groups (I) and (II) forming a compound or polymer containing unreacted functional groups (III). The invention also includes dendritic polymers obtainable by the process and intermediates obtainable in the process.